SecBot SecBot
Insider Cluster (2 insiders) ·Filed Nov 13, 2026

ABCL

AbCellera Biologics Inc.
BULLISH
Impact 4/10
Horizonweeks Processed3d 12h ago
Insider cluster: 2 insiders, $796K total
Actionable Insight ▲ Bullish

The CFO's first open-market purchase since joining and the 10% owner's material buy suggest insiders see value after the post-offering stock price. Monitor next quarter's revenue trajectory and ABCL635 Phase 3 initiation for confirmation of the growth narrative.

DirectionBullish
Confidencemedium
Horizonweeks

ABCL635

● Neutral Named in this insider cluster
Impact
Phase
Phase 2
Time to market
Phase 3 is planned to begin in 2027. Assuming a multi-year Phase 3 program followed by FDA review, potential approval would likely be 2029-2030 at the earliest, barring accelerated development.
Next catalyst
None dated

What to watchThe next major catalyst for ABCL635 is the planned Phase 3 start in 2027, which the company confirmed on its Q3 2026 earnings call. Positive Phase 2 data (83% vs 33% placebo reduction in hot flash frequency) has already been reported, so the stock's next binary event is likely years away. Watch for FDA feedback on Phase 3 trial design and any partnership/licensing deals that could validate the asset's value.

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+1
Entry
$11.49
T+0 close · Nov 13, 2026 · via day close
Latest settled
−3.22%
T+1 · $11.12
Vs SPY
−1.31%
α at T+1
Next horizon
T+5
in 3d
  1. T+0 · Nov 13 $11.49entry
  2. T+1 · 18h ago −3.22%α −1.31% · $11.12
  3. T+5 · in 3d Pending
  4. T+20 · in 27d Pending
  5. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two insiders at AbCellera, including the CFO and a 10% owner, made open-market purchases totaling $796K in the week following Q3 earnings that showed 19% revenue growth and a narrower net loss. The CFO's $97K buy and the 10% owner's $699K buy, both outside 10b5-1 plans, signal insider confidence after positive Phase 2 data and a completed $200M equity offering.

Key Financial Metrics

Direction
buying
Total Value
$796.0K
Insiders
2

Key Facts

  • CFO Andrew Booth purchased 8,600 shares at $11.33 for $97K on 2026-11-13 (no 10b5-1 plan)
  • 10% owner Thermopylae Holdings purchased 60,565 shares at $11.54 for $699K on 2026-11-12 (no 10b5-1 plan)
  • Total open-market purchases: $796K
  • Q3 2026 revenue $10.6M (+19% YoY), net loss narrowed to $40.8M from $57.1M
  • Positive Phase 2 data for ABCL635 in menopausal hot flashes announced
  • Company completed a $200M equity offering and held >$890M in liquidity

Financial Impact

Insider purchases total $796K, representing approximately 0.24% of market cap (estimated from $11.54 price and 292M shares outstanding from prior filings)

insider ownershipmarket confidence

Risk Factors

  • Company remains unprofitable with a $40.8M quarterly net loss
  • Recent $200M equity offering diluted existing shareholders
  • Insider purchases are small relative to market cap (0.24%) and may not predict near-term stock performance

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ABCL-1794845733049

Track record

16 reports on ABCL

Performance horizon

6 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +127.09% at T+20 after the Jul 29, 2026 report. 7 of 9 went positive at some point.

Filters
  1. Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $11.63 Now $11.12 −4.39% settles Feb 12
  2. Nov 13, 20263d ago Insider Cluster Bullish 4/10 Viewing Entry $11.49 Now $11.12 −3.22% settles Feb 11
  3. Nov 13, 20263d ago Insider Cluster Bullish 4/10 Entry $11.49 Now $11.12 −3.22% settles Feb 11
  4. Nov 9, 20267d ago 8-K Neutral 5/10 Entry $12.46 Now $11.12 −10.75% settles Feb 8
  5. Aug 24, 202612w ago Insider Cluster Mixed 5/10 Entry $12.50 Now $11.12 −11.04% settles Nov 18
  6. Aug 18, 202612w ago Insider Cluster Bullish 5/10 Entry $11.12 to $11.95 Now $11.12 −0.00% ▲ +7.46% +8.46% vs SPY
  7. Aug 15, 202613w ago Institutional Cluster Bearish 6/10 Entry $11.20 to $12.46 Now $11.12 +0.71% ▼ −11.25% −14.19% vs SPY
  8. Aug 11, 202613w ago 424B5 Bearish 7/10 Entry $10.36 to $11.13 Now $11.12 −7.39% ▼ −7.48% −12.60% vs SPY
  9. Aug 10, 202614w ago 8-K Bullish 7/10 Entry $9.34 to $12.18 Now $11.12 +19.06% ▲ +30.41% +32.82% vs SPY
  10. Jul 29, 202615w ago 8-K Bullish 6/10 Entry $5.39 to $11.37 Now $11.12 +106.31% ▲ +110.95% +106.22% vs SPY
Showing 10 of 16

US Market Status

Market Closed · Opens in 8h 29m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026